Hepatitis B: evolving epidemiology and implications for control.
about
Epidemiology and Prevention of Hepatitis B Virus InfectionHepatitis B virus: inactive carriersHigh rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial.Direct acting antivirals for the treatment of chronic viral hepatitisRole of lamivudine in the treatment of chronic hepatitis B virus infectionA debunking of the myth of healthy Asian Americans and Pacific Islanders.Adherence to the screening program for HBV infection in pregnant women delivering in Greece.The role of mutations in core protein of hepatitis B virus in liver fibrosisUpdate on diagnosis, management, and prevention of hepatitis B virus infection.Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention.Cost-effectiveness of a potential vaccine for human papillomavirus.Sexually transmitted diseases in children: herpes simplex virus infection, cytomegalovirus infection, hepatitis B virus infection and molluscum contagiosumHepatitis B: an important public health issue.HIV-1, HBV, HCV, HTLV, HPV-16/18, and Treponema pallidum infections in a sample of Brazilian men who have sex with menHepatitis B virus infection among street youths in MontrealNatural history of chronic hepatitis B: phases in a complex relationship.Magnitude and pattern of hepatitis B infection in clinically suspected infectious hepatitis at a tertiary care hospital in urban India.Analysis of precore/core covariances associated with viral kinetics and genotypes in hepatitis B e antigen-positive chronic hepatitis B patients.Hepatitis B Immunization of Athletic Trainers in NATA District IXPrediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.Hepatitis B and hepatitis C co-infection in patients with HIV.Immunology update: hepatitis B virus immunization todayCommunity acquired viral hepatitis B and C in the United StatesHepatitis B: transmission and natural historyCurrent status of antiviral therapy for hepatitis BTherapeutic management of hepatitis B-related cirrhosis.Quantitative detection of hepadnavirus-infected lymphoid cells by in situ PCR combined with flow cytometry: implications for the study of occult virus persistence.Hepatitis B prevention and control: Lessons from the East and the WestHepatitis B vaccination practices in state and federal prisonsAssociation of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis.Economic analysis of promotion of hepatitis B vaccinations among Vietnamese-American children and adolescents in Houston and Dallas.Hepatitis B virus genotype distribution and genotype-specific BCP/preCore substitutions in acute and chronic infections in Argentina.Chronic hepatitis B and C. What is the status of drug therapy?Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapyNatural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complicationsHepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners.Prevention of perinatal hepatitis B virus transmission in an obstetric/infant population.Women and infectious diseasesSeroepidemiology of HBV infection in South Korea, 1995 through 1999.Interleukin-10 genotype correlated to deficiency syndrome in hepatitis B cirrhosis.
P2860
Q24810152-155A2BC7-9598-4ED4-A33E-146995E1C0D8Q24810833-1BE5F0CC-B067-4A23-A035-03C228A22574Q24814210-18035DD4-7FC2-4FC3-9455-A8E294679F42Q27022216-73C89F95-7C02-41BF-BE6E-12CB467077CBQ28375031-0059138A-30BF-4871-89BA-9AB84C1C07DDQ30663954-71C9CEF0-5268-4FB4-A199-206379DBF55BQ33242733-6253E25D-7C62-4325-8A92-22BCEDEE1901Q33567791-DEB78CA7-24CB-4EA2-B983-07485D3A862EQ33588921-76D4C71E-5F07-4E32-9EA4-F25AC76D6479Q33727105-59112049-7781-4490-B7D5-0FD028DE3438Q33865463-64AAC271-4E7D-4BE2-B4C9-B7C4A660D653Q33934491-0E68699D-95B0-49CB-A366-53860E6D532BQ33947147-3EA28DA5-5984-499B-BB7D-FA7DD905E687Q33988921-4508B6C6-E99F-43FD-B72C-3084354D1DD2Q34032411-7FD492F0-0C5A-4F55-AABE-0D6A5CA0378DQ34036650-BC3EA8EC-88A4-4F2A-A44F-0A1C531DA976Q34101388-F67D72A8-5771-42E4-A7C5-6DEF0222A939Q34182782-9B10AA85-571A-4F96-8DE7-FD788FBA777FQ34239868-22E31926-22C8-4CFF-8BB3-65E2D85F0B51Q34264888-7455FA7A-F51D-4666-81E6-74CA9C15A547Q34323219-1266D72F-A5AB-4B7D-A829-B0BE5F7E3A3CQ34331387-EE3DBD75-F7A1-4F8F-9E1F-4B2CCEAA1861Q34375662-17D35A68-2A63-46BE-BAD1-E60A066D363CQ34375689-FF7B8753-F08A-4FCA-90DE-F330CF233481Q34408879-9D014286-5D13-48BA-8D6B-C90779E59826Q34434784-7A82E6AA-5083-4CA1-A133-5877D0EA0AFEQ34465832-65A7EF00-5A9B-4AD1-ACD5-9AE912E1E6B0Q34695171-E8D34E65-AB2C-4BDB-899A-EA8470DDB729Q34754809-4B48DC80-D92B-4784-847C-88F78A425475Q34985468-E3474B83-1F34-492C-B36E-23C9EA0B2179Q35100811-945A9BA0-2986-4078-A89A-B394A75A5455Q35231194-D4A52725-DB65-47B0-964D-C12AB93AAD98Q35337473-9226DF60-AACF-488A-AEB5-5AD0FEE6140FQ35501225-885474BC-B4EF-4787-8AB3-63EEFC2FCB27Q35596530-33AAEE0F-E6E0-47A7-A0FA-A0DE82963F1EQ35635366-7F465E95-FEA3-45D6-AA62-64A9283944A7Q35649778-6BB24171-D9AB-41D7-A2F9-B93E7E76F607Q35896156-752949BF-ADC3-48CB-99BB-D4B923CAB185Q35937614-7D1B4A8D-CB18-425E-8152-2F7E639840DBQ36011868-AC906FA7-FD11-48C1-895E-A4F578B698C6
P2860
Hepatitis B: evolving epidemiology and implications for control.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B: evolving epidemiology and implications for control.
@en
Hepatitis B: evolving epidemiology and implications for control.
@nl
type
label
Hepatitis B: evolving epidemiology and implications for control.
@en
Hepatitis B: evolving epidemiology and implications for control.
@nl
prefLabel
Hepatitis B: evolving epidemiology and implications for control.
@en
Hepatitis B: evolving epidemiology and implications for control.
@nl
P2093
P356
P1476
Hepatitis B: evolving epidemiology and implications for control.
@en
P2093
P356
10.1055/S-2008-1040427
P577
1991-05-01T00:00:00Z